<VariationArchive RecordType="classified" VariationID="208627" VariationName="NM_006306.4(SMC1A):c.3549_3552dup (p.Ile1185fs)" VariationType="Duplication" Accession="VCV000208627" Version="4" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-04-25" DateCreated="2015-12-15" MostRecentSubmission="2020-12-07">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="205197" VariationID="208627">
      <GeneList>
        <Gene Symbol="SMC1A" FullName="structural maintenance of chromosomes 1A" GeneID="8243" HGNC_ID="HGNC:11111" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xp11.22</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53374149" stop="53422728" display_start="53374149" display_stop="53422728" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53401069" stop="53449617" display_start="53401069" display_stop="53449617" Strand="-" />
          </Location>
          <OMIM>300040</OMIM>
          <Haploinsufficiency last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-07-23" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SMC1A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006306.4(SMC1A):c.3549_3552dup (p.Ile1185fs)</Name>
      <CanonicalSPDI>NC_000023.11:53380685:GGCC:GGCCGGCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>Xp11.22</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="53380685" stop="53380686" display_start="53380685" display_stop="53380686" variantLength="4" positionVCF="53380685" referenceAlleleVCF="T" alternateAlleleVCF="TGGCC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="53407606" stop="53407607" display_start="53407606" display_stop="53407607" variantLength="4" positionVCF="53407606" referenceAlleleVCF="T" alternateAlleleVCF="TGGCC" />
      </Location>
      <ProteinChange>I1163fs</ProteinChange>
      <ProteinChange>I1185fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.53407607_53407610dup" Assembly="GRCh37">
            <Expression>NC_000023.10:g.53407607_53407610dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.53380686_53380689dup" Assembly="GRCh38">
            <Expression>NC_000023.11:g.53380686_53380689dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_006988.2" sequenceAccession="NG_006988" sequenceVersion="2" change="g.46982_46985dup">
            <Expression>NG_006988.2:g.46982_46985dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001281463.1" sequenceAccession="NM_001281463" sequenceVersion="1" change="c.3483_3486dup">
            <Expression>NM_001281463.1:c.3483_3486dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001268392.1" sequenceAccession="NP_001268392" sequenceVersion="1" change="p.Ile1163fs">
            <Expression>NP_001268392.1:p.Ile1163fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006306.4" sequenceAccession="NM_006306" sequenceVersion="4" change="c.3549_3552dup" MANESelect="true">
            <Expression>NM_006306.4:c.3549_3552dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006297.2" sequenceAccession="NP_006297" sequenceVersion="2" change="p.Ile1185fs">
            <Expression>NP_006297.2:p.Ile1185fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_773" sequenceAccession="LRG_773">
            <Expression>LRG_773:g.46982_46985dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_773t1" sequenceAccession="LRG_773t1">
            <Expression>LRG_773t1:c.3483_3486dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_773p1" sequenceAccession="LRG_773p1" change="p.Ile1163fs">
            <Expression>LRG_773p1:p.Ile1163fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006306.3" sequenceAccession="NM_006306" sequenceVersion="3" change="c.3549_3552dupGGCC">
            <Expression>NM_006306.3:c.3549_3552dupGGCC</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA277857" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300040.0009" DB="OMIM" />
        <XRef Type="rs" ID="863225459" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006306.4(SMC1A):c.3549_3552dup (p.Ile1185fs) AND Congenital muscular hypertrophy-cerebral syndrome" Accession="RCV000202430" Version="2">
        <ClassifiedConditionList TraitSetID="3183">
          <ClassifiedCondition DB="MedGen" ID="C1802395">Congenital muscular hypertrophy-cerebral syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-09-08" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_006306.4(SMC1A):c.3549_3552dup (p.Ile1185fs) AND Developmental and epileptic encephalopathy, 85, with or without midline brain defects" Accession="RCV001072125" Version="2">
        <ClassifiedConditionList TraitSetID="53185">
          <ClassifiedCondition DB="MedGen" ID="C5393312">Developmental and epileptic encephalopathy, 85, with or without midline brain defects</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2015-10-01" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2015-09-08" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2015-12-15" MostRecentSubmission="2020-12-07">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">26386245</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="53185" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="43829" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">EPILEPTIC ENCEPHALOPATHY, EARLY INFANTILE, 85, WITH OR WITHOUT MIDLINE BRAIN DEFECTS</ElementValue>
                <XRef Type="MIM" ID="301044" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Developmental and epileptic encephalopathy, 85, with or without midline brain defects</ElementValue>
                <XRef ID="MONDO:0026771" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">EIEE85</ElementValue>
                <XRef Type="MIM" ID="301044" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">DEE85</ElementValue>
                <XRef Type="MIM" ID="301044" DB="OMIM" />
              </Symbol>
              <XRef ID="C5393312" DB="MedGen" />
              <XRef ID="MONDO:0026771" DB="MONDO" />
              <XRef Type="MIM" ID="301044" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="3183" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4850" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Congenital muscular hypertrophy-cerebral syndrome</ElementValue>
                <XRef ID="Congenital+muscular+hypertrophy-cerebral+syndrome/8077" DB="Genetic Alliance" />
                <XRef ID="55016009" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Cornelia de Lange syndrome 2</ElementValue>
                <XRef ID="MONDO:0010370" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">CDLS2</ElementValue>
                <XRef Type="MIM" ID="300590" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Cornelia de Lange syndrome (CdLS) encompasses a spectrum of findings from mild to severe. Severe (classic) CdLS is characterized by distinctive facial features, growth restriction (prenatal onset; &lt;5th centile throughout life), hypertrichosis, and upper-limb reduction defects that range from subtle phalangeal abnormalities to oligodactyly (missing digits). Craniofacial features include synophrys, highly arched and/or thick eyebrows, long eyelashes, short nasal bridge with anteverted nares, small widely spaced teeth, and microcephaly. Individuals with a milder phenotype have less severe growth, cognitive, and limb involvement, but often have facial features consistent with CdLS. Across the CdLS spectrum IQ ranges from below 30 to 102 (mean: 53). Many individuals demonstrate autistic and self-destructive tendencies. Other frequent findings include cardiac septal defects, gastrointestinal dysfunction, hearing loss, myopia, and cryptorchidism or hypoplastic genitalia.</Attribute>
                <XRef ID="NBK1104" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301283</ID>
                <ID Source="BookShelf">NBK1104</ID>
              </Citation>
              <XRef ID="199" DB="Orphanet" />
              <XRef ID="C1802395" DB="MedGen" />
              <XRef ID="MONDO:0010370" DB="MONDO" />
              <XRef Type="MIM" ID="300590" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="454430" SubmissionDate="2015-09-09" DateLastUpdated="2015-12-15" DateCreated="2015-12-15">
        <ClinVarSubmissionID localKey="NM_006306.3:c.3549_3552dupGGCC|OMIM:300590" />
        <ClinVarAccession Accession="SCV000245565" DateUpdated="2015-12-15" DateCreated="2015-12-15" Type="SCV" Version="1" SubmitterName="Center for Human Genetics, University Hospitals Case Medical Center/Case Western Reserve University" OrgID="505514" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-09-08">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">26386245</ID>
          </Citation>
          <Comment>Developmental delay and seizures, with either mild or absent classic CdLS facial features.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Submitter's publication</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">26386245</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>de novo</Origin>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">0</Age>
              <Age Type="maximum" age_unit="years">9</Age>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMC1A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006306.3:c.3549_3552dupGGCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Cornelia de Lange Syndrome 2</ElementValue>
            </Name>
            <XRef DB="OMIM" ID="300590" Type="MIM" />
          </Trait>
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">CDLS2</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <Citation Type="general">
          <ID Source="PubMed">26386245</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26386245</ID>
        </Citation>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2440762" SubmissionDate="2020-12-01" DateLastUpdated="2020-12-07" DateCreated="2020-04-18">
        <ClinVarSubmissionID localKey="300040.0009_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH MIDLINE BRAIN DEFECTS" title="SMC1A, 4-BP DUP, 3549GGCC_DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH MIDLINE BRAIN DEFECTS" />
        <ClinVarAccession Accession="SCV001237468" DateUpdated="2020-12-07" DateCreated="2020-04-18" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-10-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a 3-year-old girl (patient B) with developmental and epileptic encephalopathy-85 and slight thinning of the corpus callosum (DEE85; 301044), Goldstein et al. (2015) identified a de novo heterozygous 4-bp duplication (c.3549_3552dupGGCC, NM_006306) in exon 24 of the SMC1A gene, resulting in a frameshift and premature termination (Ile1185GlyfsTer23). The mutation was found by whole-exome sequencing and confirmed by Sanger sequencing. X-inactivation studies in peripheral blood cells showed a random pattern. Additional functional studies of the variant and studies of patient cells were not performed. The patient had onset of tonic-clonic movements at 17 months of age following earlier global developmental delay.</Attribute>
              <Citation>
                <ID Source="PubMed">26386245</ID>
              </Citation>
              <XRef DB="OMIM" ID="301044" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SMC1A" />
          </GeneList>
          <Name>SMC1A, 4-BP DUP, 3549GGCC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 3549GGCC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300040.0009" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">DEVELOPMENTAL AND EPILEPTIC ENCEPHALOPATHY 85 WITH MIDLINE BRAIN DEFECTS</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="454430" TraitType="Disease" MappingType="Name" MappingValue="Cornelia de Lange Syndrome 2" MappingRef="Preferred">
        <MedGen CUI="C1802395" Name="Congenital muscular hypertrophy-cerebral syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="454430" TraitType="Disease" MappingType="Name" MappingValue="CDLS2" MappingRef="Preferred">
        <MedGen CUI="C1802395" Name="Congenital muscular hypertrophy-cerebral syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

